Dashboard
Manage Tickers

GKOS GLAUKOS Corp

NYSE glaukos.com


$ 93.42 $ -0.70 (-0.9 %)    

Wednesday, 29-Oct-2025 19:55:31 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 634.74 $ 2.85 (0.45 %)
DIA $ 476.09 $ -0.78 (-0.16 %)
SPY $ 686.84 $ 0.33 (0.05 %)
TLT $ 90.87 $ -0.93 (-1.01 %)
GLD $ 363.50 $ -1.38 (-0.38 %)
$ 77.09
$ 77.07
$ 93.01 x 8
$ 93.70 x 14
$ 76.88 - $ 81.00
$ 73.16 - $ 163.71
2,372,113
na
4.42B
$ 1.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-04-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-24-2025 12-31-2024 10-K
4 11-04-2024 09-30-2024 10-Q
5 08-02-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-23-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-24-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-28-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 03-01-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 03-02-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-06-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 02-28-2018 12-31-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-07-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 03-15-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-04-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
40 11-12-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/29/2025 21:06:30

glaukos-raises-fy2025-sales-guidance-from-480000m-486000m-to-490000m-495000m-vs-484630m-est
Glaukos Raises FY2025 Sales Guidance from ...
10/29/2025 20:07:23

Glaukos (NYSE:GKOS) raises FY2025 sales outlook from $480.000 million-$486.000 million to $490.000 million-$495.000 million vs ...

glaukos-q3-adj-eps-016-beats-026-estimate-sales-133537m-beat-122540m-estimate
Glaukos Q3 Adj. EPS $(0.16) Beats $(0.26) ...
10/29/2025 20:06:50

Glaukos (NYSE:GKOS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.26) by 37.9...

earnings-scheduled-for-october-29-2025
Earnings Scheduled For October 29, 2025
10/29/2025 11:11:56

booking-holdings-to-rally-around-12-here-are-10-top-analyst-forecasts-for-monday
Booking Holdings To Rally Around 12%? Here...
10/27/2025 12:00:54

this-five-below-analyst-turns-bullish-here-are-top-5-upgrades-for-monday
This Five Below Analyst Turns Bullish; Her...
10/27/2025 11:29:57

wells-fargo-upgrades-glaukos-to-overweight-raises-price-target-to-120
Wells Fargo Upgrades Glaukos to Overweight...
10/27/2025 11:16:07

Wells Fargo analyst Larry Biegelsen upgrades Glaukos (NYSE:GKOS) from Equal-Weight to Overweight and raises the price target...

btig-reiterates-buy-on-glaukos-maintains-104-price-target
BTIG Reiterates Buy on Glaukos, Maintains ...
10/20/2025 12:27:35

BTIG analyst Ryan Zimmerman reiterates Glaukos (NYSE:GKOS) with a Buy and maintains $104 price target.

the-fda-approves-glaukos-epioxa-hdepioxa-as-first-incision-free-topical-drug-therapy-for-keratoconus-epioxa-is-expected-to-be-commercially-available-in-q1-2026
The FDA Approves Glaukos' Epioxa HD/Epioxa...
10/20/2025 11:04:58

expert-outlook-glaukos-through-the-eyes-of-7-analysts
Expert Outlook: Glaukos Through The Eyes O...
10/13/2025 14:00:44

btig-maintains-buy-on-glaukos-lowers-price-target-to-104
BTIG Maintains Buy on Glaukos, Lowers Pric...
10/13/2025 12:07:45

BTIG analyst Ryan Zimmerman maintains Glaukos (NYSE:GKOS) with a Buy and lowers the price target from $118 to $104.

citigroup-maintains-buy-on-glaukos-lowers-price-target-to-110
Citigroup Maintains Buy on Glaukos, Lowers...
10/07/2025 17:04:34

Citigroup analyst Joanne Wuensch maintains Glaukos (NYSE:GKOS) with a Buy and lowers the price target from $140 to $110.

goldman-sachs-initiates-coverage-on-glaukos-with-buy-rating-announces-price-target-of-103
Goldman Sachs Initiates Coverage On Glauko...
10/01/2025 17:49:00

Goldman Sachs analyst David Roman initiates coverage on Glaukos (NYSE:GKOS) with a Buy rating and announces Price Target of ...

expert-outlook-glaukos-through-the-eyes-of-4-analysts
Expert Outlook: Glaukos Through The Eyes O...
09/22/2025 19:01:24

truist-securities-maintains-buy-on-glaukos-lowers-price-target-to-120
Truist Securities Maintains Buy on Glaukos...
09/22/2025 14:25:57

Truist Securities analyst Richard Newitter maintains Glaukos (NYSE:GKOS) with a Buy and lowers the price target from $126 to...

btig-reiterates-buy-on-glaukos-maintains-118-price-target
BTIG Reiterates Buy on Glaukos, Maintains ...
09/10/2025 10:37:24

BTIG analyst Ryan Zimmerman reiterates Glaukos (NYSE:GKOS) with a Buy and maintains $118 price target.

wells-fargo-maintains-equal-weight-on-glaukos-raises-price-target-to-92
Wells Fargo Maintains Equal-Weight on Glau...
07/31/2025 15:40:42

Wells Fargo analyst Larry Biegelsen maintains Glaukos (NYSE:GKOS) with a Equal-Weight and raises the price target from $86 t...

ubs-maintains-buy-on-glaukos-raises-price-target-to-134
UBS Maintains Buy on Glaukos, Raises Price...
07/31/2025 13:04:34

UBS analyst Danielle Antalffy maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $125 to $134.

glaukos-raises-fy2025-sales-guidance-from-47500m-48500m-to-48000m-48600m-vs-48078m-est
Glaukos Raises FY2025 Sales Guidance from ...
07/30/2025 20:13:39

Glaukos (NYSE:GKOS) raises FY2025 sales outlook from $475.00 million-$485.00 million to $480.00 million-$486.00 million vs $480...

glaukos-q2-adj-eps-024-beats-026-estimate-sales-12412m-beat-11551m-estimate
Glaukos Q2 Adj. EPS $(0.24) Beats $(0.26) ...
07/30/2025 20:13:03

Glaukos (NYSE:GKOS) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.26) by 7.34...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION